BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Behind regulatory milestones like the recent accelerated FDA a
 pproval for Duchenne Muscular Dystrophy\, robust and detailed analytics a
 re the cornerstone of gene therapy development. As regulators scrutinize 
 products more closely\, accurately characterizing gene therapy products a
 nd standing behind safety and efficacy is crucial to drug developers brin
 ging gene therapies into and through the clinic.\n\nIn this context\, the
  5th Annual Gene Therapy Analytical Development is returning in 2023\, un
 iting 400+ analytical experts to explore how the latest analytical method
 s are being developed and applied to guarantee the quality\, consistency\
 , safety\, and efficacy of gene therapy products.\n\nJoin biopharma colle
 agues specializing in bioassays\, molecular biology\, physicochemical pro
 perties\, quality\, process development and regulation across 4 days of n
 iche\, expert presentations\, and dedicated networking opportunities. Thi
 s is your must-attend meeting to collaborate ideas\, success and challeng
 es to capitalize on the technological advances in analytical development 
 to reach the ultimate goal of bringing safer\, efficacious therapies to p
 atients more quickly and effectively.\n
DTEND:20231130T170000
DTSTAMP:20260512T232256Z
DTSTART:20231127T080000
LOCATION:Boston Park Plaza\, 50\, 50 Park Plaza\, Boston\, Massachusetts\,
  02116\,
SEQUENCE:0
SUMMARY:Behind regulatory milestones like the recent accelerated FDA appro
 val for Duchenne Muscular Dystrophy\, robust and detailed analytics are t
 he corner...
UID:ce4e11fc-4fe1-43cd-9e4e-31c8123149e8
END:VEVENT
END:VCALENDAR